Last reviewed · How we verify
chlorozotocin
chlorozotocin is a drug. It is currently in unknown development.
Chlorozotocin works by interfering with DNA synthesis, which prevents cancer cells from growing and dividing.
Chlorozotocin is a small molecule originally developed by the National Cancer Institute. Its target and drug class are unknown, and it is not FDA-approved for any indications. As a result, there is limited information available on its commercial status, pharmacokinetics, or safety profile. Further research is needed to fully understand the properties and potential applications of chlorozotocin. Its development status and potential uses remain unclear.
At a glance
| Generic name | chlorozotocin |
|---|---|
| Therapeutic area | Oncology |
| Phase | unknown |
Mechanism of action
Imagine your body's cells are like a factory, and DNA is the blueprint for making new parts. Chlorozotocin disrupts this blueprint, making it difficult for cancer cells to produce the parts they need to grow and multiply. This helps to slow down or stop the growth of cancer.
Approved indications
Common side effects
Key clinical trials
- Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers (PHASE1)
- Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19 (PHASE1,PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- chlorozotocin CI brief — competitive landscape report
- chlorozotocin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about chlorozotocin
What is chlorozotocin?
How does chlorozotocin work?
What development phase is chlorozotocin in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Oncology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing